Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Breast Cancer

Free Subscription Articles published in Am J Clin Pathol Retrieve available abstracts of 17 articles: HTML format

Single Articles

March 2023
1. FINE JL
   Lining Up the Pieces: Coregistration of Digital Pathology Images Is an Underused Technique With Great Promise in Advancing Computational Pathology.
   Am J Clin Pathol. 2023;159:209-210.
   PubMed    
   
   
   
2. SOMPURAM SR, Vani K, Ryan L, Johnson C, et al
   Validation of Linear Range HER2/Estrogen Receptor/Progesterone Receptor IHControls for Daily Quality Assurance.
   Am J Clin Pathol. 2023;159:274-282.
   PubMed     Abstract available
   
   
   February 2023
3. KARAKAS C, Tyburski H, Turner BM, Wang X, et al
   Interobserver and Interantibody Reproducibility of HER2 Immunohistochemical Scoring in an Enriched HER2-Low-Expressing Breast Cancer Cohort.
   Am J Clin Pathol. 2023 Feb 28:aqac184. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. ZHANG M, Liao J, Jia Z, Qin C, et al
   High Dynamic Range Dual-Modal White Light Imaging Improves the Accuracy of Tumor Bed Sampling After Neoadjuvant Therapy for Breast Cancer.
   Am J Clin Pathol. 2023 Feb 17:aqac167. doi: 10.1093.
   PubMed     Abstract available
   
   
   January 2023
5. WOLTERS EA, Rabe KE, Siegel L, Butts J, et al
   Histopathologic Features of Breast Tissue From Transgender Men and Their Associations With Androgen Therapy.
   Am J Clin Pathol. 2023;159:43-52.
   PubMed     Abstract available
   
   
   November 2022
6. RAMMAL R, Goel K, Elishaev E, Rinda Soong T, et al
   The Utility of SOX10 Immunohistochemical Staining in Breast Pathology.
   Am J Clin Pathol. 2022;158:616-625.
   PubMed     Abstract available
   
   
   September 2022
7. WANG M, Stendahl K, Cai G, Adeniran A, et al
   Evaluation of TRPS1 Expression in Pleural Effusion Cytology Specimens With Metastatic Breast Carcinoma.
   Am J Clin Pathol. 2022;158:416-425.
   PubMed     Abstract available
   
   
   
8. BEDI D, Clark BZ, Carter GJ, Yu J, et al
   Prognostic Significance of Three-Tiered World Health Organization Classification of Phyllodes Tumor and Correlation to Singapore General Hospital Nomogram.
   Am J Clin Pathol. 2022;158:362-371.
   PubMed     Abstract available
   
   
   June 2022
9. YOUSIF M, Huang Y, Sciallis A, Kleer CG, et al
   Quantitative Image Analysis as an Adjunct to Manual Scoring of ER, PgR, and HER2 in Invasive Breast Carcinoma.
   Am J Clin Pathol. 2022;157:899-907.
   PubMed     Abstract available
   
   
   
10. VYAS M, Hissong E, Gonzalez RS, Shia J, et al
    Metastatic Neoplasms Involving the Stomach.
    Am J Clin Pathol. 2022;157:863-873.
    PubMed     Abstract available
    
    
    April 2022
11. LI F, Zhao Y, Wei Y, Xi Y, et al
    Tumor-Infiltrating Lymphocytes Improve Magee Equation-Based Prediction of Pathologic Complete Response in HR-Positive/HER2-Negative Breast Cancer.
    Am J Clin Pathol. 2022 Apr 29. pii: 6576131. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2022
12. ZHANG H, Katerji H, Turner BM, Hicks DG, et al
    HER2-Low Breast Cancers.
    Am J Clin Pathol. 2022;157:328-336.
    PubMed     Abstract available
    
    
    February 2022
13. MA LX, Michaels AY, Ginter PS
    Subareolar Tissue Biopsy Predicts Occult Nipple Involvement in Nipple-Sparing Mastectomies.
    Am J Clin Pathol. 2022;157:266-272.
    PubMed     Abstract available
    
    
    November 2021
14. MOHANTY SK, Mishra SK, Tiwari A, Sharma S, et al
    Reappraisal of HER2 Amplification in High-Grade Urothelial Carcinoma Based on 2018 ASCO/CAP Clinical Practice Guidelines.
    Am J Clin Pathol. 2021;156:1130-1141.
    PubMed     Abstract available
    
    
    October 2021
15. GEIERSBACH KB, Sill DR, Del Rosario KM, Meyer RG, et al
    Detailed Reanalysis of 500 Breast Cancers With Equivocal HER2 Immunohistochemistry and Borderline ERBB2 Fluorescence In Situ Hybridization Results.
    Am J Clin Pathol. 2021;156:886-894.
    PubMed     Abstract available
    
    
    September 2021
16. ZHAN H, Quinn M, Tian W, Yan L, et al
    Significance of Removing Comedonecrosis as an Exclusion Criterion in Mammary Low-Risk Ductal Carcinoma In Situ Managed in an Active Surveillance Clinical Trial.
    Am J Clin Pathol. 2021;156:596-606.
    PubMed     Abstract available
    
    
    
17. AMIN A, Yasmeen S, Jeyachandran D, Khoury T, et al
    Diagnostic Utility and Significance of Performing Multistep Level Sections in Breast and Gynecologic Biopsy Specimens.
    Am J Clin Pathol. 2021;156:620-624.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: